De-Hua Wu (Dehua Wu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Breast Cancer Cells

Rheumatoid Arthritis Patients

Top Venues

Cancer research

Communications biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Qian-Nan Ren, Dan-Hui Huang, Xiao-Nan Zhang, Yue-Ning Wang, Yu-Feng Zhou, Mei-Yin Zhang, Shuo-Cheng Wang, Shi-Juan Mai, De-Hua Wu, Hui-Yun Wang
Two somatic mutations in the androgen receptor N-terminal domain are oncogenic drivers in hepatocellular carcinoma. Communications biology 7 (1) (2024)
Qian-Nan Ren, Dan-Hui Huang, Xiao-Nan Zhang, Yue-Ning Wang, Yu-Feng Zhou, Mei-Yin Zhang, Shuo-Cheng Wang, Shi-Juan Mai, De-Hua Wu, Hui-Yun Wang
Two somatic mutations in the androgen receptor N-terminal domain are oncogenic drivers in hepatocellular carcinoma. Communications biology 7 (1) (2024)
Qian-Nan Ren, Dan-Hui Huang, Xiao-Nan Zhang, Yue-Ning Wang, Yu-Feng Zhou, Mei-Yin Zhang, Shuo-Cheng Wang, Shi-Juan Mai, De-Hua Wu, Hui-Yun Wang
Two somatic mutations in the androgen receptor N-terminal domain are oncogenic drivers in hepatocellular carcinoma. Communications biology 7 (1) (2024)
Qian-Nan Ren, Dan-Hui Huang, Xiao-Nan Zhang, Yue-Ning Wang, Yu-Feng Zhou, Mei-Yin Zhang, Shuo-Cheng Wang, Shi-Juan Mai, De-Hua Wu, Hui-Yun Wang
Two somatic mutations in the androgen receptor N-terminal domain are oncogenic drivers in hepatocellular carcinoma. Communications biology 7 (1) (2024)
Li-Li Long, Si-Cong Ma, Ze-Qin Guo, Yan-Pei Zhang, Zhenzhen Fan, Li-Juan Liu, Li Liu, Duan-Duan Han, Meng-Xin Leng, Jian Wang, Xue-Jun Guo, Jia-Le Tan, Xiao-Ting Cai, Yan Lin, Xinghua Pan, De-Hua Wu, Xue Bai, Zhong-Yi Dong
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer. Cancer research 83 (4) (2023)
Zhaoze Guo, Han Zhang, Yiming Fu, Junjie Kuang, Bei Zhao, LanFang Zhang, Jie Lin, Shuhui Lin, De-Hua Wu, Guozhu Xie
Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6. Cell death discovery 9 (1) (2023)
Xue Bai, Ze-Qin Guo, Yan-Pei Zhang, Zhen-Zhen Fan, Li-Juan Liu, Li Liu, Li-Li Long, Si-Cong Ma, Jian Wang, Yuan Fang, Xin-Ran Tang, Yu-Jie Zeng, Xinghua Pan, De-Hua Wu, Zhong-Yi Dong
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy. Nature communications 14 (1) (2023)
Xue Bai, Ze-Qin Guo, Yan-Pei Zhang, Zhen-Zhen Fan, Li-Juan Liu, Li Liu, Li-Li Long, Si-Cong Ma, Jian Wang, Yuan Fang, Xin-Ran Tang, Yu-Jie Zeng, Xinghua Pan, De-Hua Wu, Zhong-Yi Dong
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy. Nature communications 14 (1) (2023)
Zhaoze Guo, Han Zhang, Yiming Fu, Junjie Kuang, Bei Zhao, LanFang Zhang, Jie Lin, Shuhui Lin, De-Hua Wu, Guozhu Xie
Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6. Cell death discovery 9 (1) (2023)
Xue Bai, Ze-Qin Guo, Yan-Pei Zhang, Zhen-Zhen Fan, Li-Juan Liu, Li Liu, Li-Li Long, Si-Cong Ma, Jian Wang, Yuan Fang, Xin-Ran Tang, Yu-Jie Zeng, Xinghua Pan, De-Hua Wu, Zhong-Yi Dong
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy. Nature communications 14 (1) (2023)
Li-Li Long, Si-Cong Ma, Ze-Qin Guo, Yan-Pei Zhang, Zhenzhen Fan, Li-Juan Liu, Li Liu, Duan-Duan Han, Meng-Xin Leng, Jian Wang, Xue-Jun Guo, Jia-Le Tan, Xiao-Ting Cai, Yan Lin, Xinghua Pan, De-Hua Wu, Xue Bai, Zhong-Yi Dong
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer. Cancer research 83 (4) (2023)
Li-Li Long, Si-Cong Ma, Ze-Qin Guo, Yan-Pei Zhang, Zhenzhen Fan, Li-Juan Liu, Li Liu, Duan-Duan Han, Meng-Xin Leng, Jian Wang, Xue-Jun Guo, Jia-Le Tan, Xiao-Ting Cai, Yan Lin, Xinghua Pan, De-Hua Wu, Xue Bai, Zhong-Yi Dong
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer. Cancer research 83 (4) (2023)
Li-Li Long, Si-Cong Ma, Ze-Qin Guo, Yan-Pei Zhang, Zhenzhen Fan, Li-Juan Liu, Li Liu, Duan-Duan Han, Meng-Xin Leng, Jian Wang, Xue-Jun Guo, Jia-Le Tan, Xiao-Ting Cai, Yan Lin, Xinghua Pan, De-Hua Wu, Xue Bai, Zhong-Yi Dong
PARP inhibition induces synthetic lethality and adaptive immunity in LKB1-mutant lung cancer. Cancer research (2022)
Zhenru Zhu, Chuanhui Cao, Dongyan Zhang, Zhihong Zhang, Li Liu, De-Hua Wu, Jingyuan Sun
UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism. Cell death & disease 13 (2) (2022)
Yanling Lin, Xiaohan Zhou, Kaifan Yang, Yuting Chen, Lingzhi Wang, Wenxiao Luo, Yujiang Li, Jinrong Liao, Yingtong Zhou, Yiming Lei, Yanting Zhang, De-Hua Wu, Longmei Cai
Protein tyrosine phosphatase receptor type D gene promotes radiosensitivity via STAT3 dephosphorylation in nasopharyngeal carcinoma. Oncogene 40 (17) (2021)
Ping-Yan Liao, Zhong-Yi Dong, Chan-Tao Huang, Xin-Ran Tang, Guan-Dong Liu, null Zhu-Liu, De-Hua Wu
Development and Validation of a Prognostic Nomogram Based on Residual Tumor in Patients With Nondisseminated Nasopharyngeal Carcinoma. Technology in cancer research & treatment 19 (2021)
Yuan Fang, Yizhi Zhan, Yuwen Xie, Shisuo Du, Yuhan Chen, Zhaochong Zeng, Yaowei Zhang, Keli Chen, Yongjia Wang, Li Liang, Yi Ding, De-Hua Wu
Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC. Hepatology (Baltimore, Md.) (2021)
Chengdong Liu, Xiaohan Zhou, Qian Long, Hanyi Zeng, Qingcan Sun, Yuting Chen, De-Hua Wu, Li Liu
Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene. Oncogene 40 (2) (2020)